Retacrit
Active Ingredient(s): Epoetin Alfa-epbxFDA Approved: * May 15, 2018
Pharm Company: * HOSPIRA INC
Category: Anemia
Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology.[3] Authorised by the European Medicines Agency on 28 August 2007, it stimulates erythropoiesis (increasing red blood cell levels) and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy. Epoetin is manufactured and marketed by Amgen under the trade name Epogen. Johnson & Johnson subsidiary Janssen Biotech (formerly Ortho Biotech Pro... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Retacrit 2000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1305
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 3000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1306
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 4000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1307
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 10000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1308
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 40000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1309
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 20000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1311
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 10000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 0069-1318
Labeler:
Pfizer Laboratories Div Pfizer Inc
Retacrit 2000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 59353-002
Labeler:
Vifor (International) Inc.
Retacrit 3000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 59353-003
Labeler:
Vifor (International) Inc.
Retacrit 4000 [Iu]/Ml Intravenous; Subcutaneous Injection, Solution
NDC: 59353-004
Labeler:
Vifor (International) Inc.
